Device Trial Radar · NCT04479787
Spinal Cord Stimulation vs. Medical Management for Low Back Pain (DISTINCT)
Last checked: Nov 20, 2026Latest source record: Feb 3, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
270
Actual
Start
Jul 31, 2020
Primary completion
Aug 23, 2022
Study completion Feb 26, 2024
Sponsor
- Lead sponsor
- Abbott Medical DevicesPublic (ABT)
- Sponsor type
- Industry
- First posted
- Jul 21, 2020
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The objective of this study is to evaluate the efficacy of BurstDR dorsal column stimulation, compared with conventional medical management, in improving pain and back-related physical function in subjects suffering with chronic, refractory axial low back pain with a neuropathic component, who have not had lumbar spine surgery and for whom surgery is not an option.
Conditions
- Chronic Low-Back Pain
- Refractory Pain
- Neuropathic Pain
Interventions
Spinal Cord StimulationDevice
Utilization of BURSTDR stimulation
Conventional Medical ManagementOther
Assessing type of CMM, location and frequency.
Primary outcomes
What the sponsor says the trial is designed to measure.
- The Difference in Responders Between Both GroupsTime frame: 6 Months
Locations
30 sites in 1 country. Site status is shown where the registry gives one.
Barrow Brain & Spine
Phoenix, Arizona
Banner University Medical Center
Tucson, Arizona
Spanish Hills Interventional Pain Specialists
Camarillo, California
27 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.